TY  - GEN
AU  - Bock,O
AU  - Boerst,H
AU  - Thomasius,F E
AU  - Degner,C
AU  - Stephan-Oelkers,M
AU  - Valentine,S M
AU  - Felsenberg,D
TI  - Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention
SN  - 1108-7161
PY  - 2007///1017
KW  - Administration, Oral
KW  - Aged
KW  - Alendronate
KW  - administration & dosage
KW  - Arthralgia
KW  - chemically induced
KW  - Back Pain
KW  - Bone Density Conservation Agents
KW  - Cohort Studies
KW  - Drug Administration Schedule
KW  - Etidronic Acid
KW  - Female
KW  - Hemiterpenes
KW  - metabolism
KW  - Humans
KW  - Injections, Intravenous
KW  - adverse effects
KW  - Lymphocyte Activation
KW  - drug effects
KW  - Male
KW  - Mevalonic Acid
KW  - Middle Aged
KW  - Musculoskeletal Diseases
KW  - Organophosphorus Compounds
KW  - Osteoporosis
KW  - drug therapy
KW  - Pain
KW  - Retrospective Studies
KW  - Risedronic Acid
KW  - T-Lymphocytes
N1  - Publication Type: Journal Article
ER  -